No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
HPGC Renmintongtai Pharmaceutical Corporation is a pharmaceutical enterprise actively involved in the wholesale and retail distribution of diverse medicinal products across China and internationally. Its extensive product portfolio encompasses traditional Chinese medicines, herbal remedies, chemical preparations, antibiotics, biologics, biochemical drugs, medical equipment, and health-related items. The company also extends its operations to include logistics services, specifically warehousing and distribution. Additionally, it offers comprehensive hospital services covering medical treatment, scientific research, disease prevention, health promotion, rehabilitation, blood purification, and renal disease management. Through its e-commerce platform, HPGC Renmintongtai markets a broad selection of items, including Chinese and Western pharmaceuticals, traditional Chinese herbs, nutritional supplements, medical devices, cosmetics, and everyday necessities. The company maintains a significant retail presence with 319 chain stores located throughout Heilongjiang Province. Established in 1950 and headquartered in Harbin, China, HPGC Renmintongtai Pharmaceutical Corporation operates as a subsidiary of Harbin Pharmaceutical Group Co., Ltd.
www.hyrmtt.com.cnNo one on the platform currently holds 600829.SS.
No tracked institution reports a position in 600829.SS as of their last filing.
No one on the platform has traded 600829.SS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 600829.SSHPGC Renmintongtai Pharmaceutical Corporation | $9.35 | +0.97% | $5.4B | — |
| 002393.SZTianjin Lisheng Pharmaceutical Co.,Ltd. | $13.39 | -0.45% | $4.0B | — |
| 002644.SZLanZhou Foci Pharmaceutical Co.,Ltd. | $8.15 | -0.37% | $4.2B | — |
| 002688.SZJinhe Biotechnology Co. Ltd. | $5.14 | +1.38% | $4.0B | — |
| 002728.SZTeyi Pharmaceutical Group Co.,Ltd | $9.15 | +0.44% | $4.7B | — |
| 300016.SZBeijing Beilu Pharmaceutical Co., Ltd | $7.96 | +0.89% | $4.6B | — |
| 300194.SZFuan Pharmaceutical (Group) Co., Ltd. | $3.77 | +0.53% | $4.5B | — |
Source: Financial Modeling Prep · peers by sector/industry